Skip to content
Search

Latest Stories

Hallo Healthcare to exit hospital pharmacy sites: PDA offers support to affected pharmacists

Hallo Healthcare to exit hospital pharmacy sites: PDA offers support to affected pharmacists

Last year, Hallo Healthcare sold all of its 1,054 high street and community pharmacies under the LloydsPharmacy brand

Hallo Healthcare has announced its decision to exit from its hospital pharmacy sites, currently operated by LloydsPharmacy Healthcare Services (LP HCS Limited), which primarily provides outpatient services.

Pharmacists and their teams at its 64 pharmacy sites were informed on Monday, 19 August 2024, about the company's plans to withdraw from this sector.


The Pharmacists’ Defence Association (PDA), the recognised trade union representing pharmacists at these sites, was also notified.

The association has assured its support for members impacted by the decision, although it noted that the process of branch transfers could take several months.

“It is expected to be several months before all such branch transfers are agreed and undertaken,” the PDA said.

The association noted that contracts to provide such services “do change hands periodically with some hospital outpatient departments (OPDs) operated by pharmacy multiples and others operated by hospital-owned subsidiaries” and highlighted its experience in supporting pharmacists when employers change in this way.

PDA Union Director Paul Day is hopeful that there will be no job losses in outpatient services and that all pharmacists will be able to continue in their current roles.

He said: “Each hospital or healthcare services site will still need a service, so it is hoped that we see no job losses in outpatients and that every pharmacist will be able to continue in their current role, albeit that their employer will change.”

However, he cautioned that new employers may try to use such transfers to change someone’s role or the terms of their employment.

Therefore, he emphasised the importance of Transfer of Undertakings Protection of Employment (TUPE) regulations that provide specific rights to those employees impacted.

The PDA encourages pharmacists to seek their support during this period of change.

Hallo Healthcare currently comprises wholesaler AAH, LloydsPharmacy Clinical Home Care, LloydsPharmacy Healthcare Services and Lloyds Online Doctor.

LloydsPharmacy Healthcare Services were first commissioned at the Royal Liverpool Hospital in 2009. Since then, the services have expanded across the UK, now supporting over 65 NHS hospitals, numerous custodial facilities, and an increasing number of private sector organisations.

Last year, the Group sold all of its 1,054 high street and community pharmacies that were operated under the LloydsPharmacy brand.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less